Skip to content

Kabat Rehabilitation Versus Mime Therapy on Facial Disability and Synkinesis in Patients of Bell's Palsy

Effects Of Kabat Rehabilitation Versus Mime Therapy On Facial Disability And Synkinesis In Patients Of Bell's Palsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06029855
Enrollment
85
Registered
2023-09-08
Start date
2023-05-01
Completion date
2023-10-15
Last updated
2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell Palsy

Keywords

Bell Palsy, Kabat Rehabilitation, Mime Therapy

Brief summary

Bell's palsy, also called idiopathic facial paralysis, is a common cause of unilateral facial paralysis. It is one of the most common neurological disorders of the cranial nerves.

Detailed description

Bell's palsy is an alarming condition of rapid onset, which paralyzes half of the facial muscles. Kabat rehabilitation is a manual resistance technique that promotes a basic pattern of movement through facilitation, inhibition, and resistance of a group of muscles. It increases the functioning and power of facial muscles while Mime therapy results in immediate improvement of function and integrity of facial muscles. It also mitigates synkinesis in Bell's palsy. Both techniques are easy to apply. They are clinically important techniques that are easily understood by patients.

Interventions

OTHERKabat Therapy

The participants of group A will receive Kabat Rehabilitation with routine physical therapy. The protocol will be given to the participants for three sessions/week for six weeks. Each session will be of 30 minutes.

The participants of group B will receive Mime Therapy in addition to routine physical therapy. The protocol will be given to the participants once a week for six weeks, while physical therapy will be given on alternate days. Each session will be of 30 minutes.

Sponsors

University of Lahore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Age group 25-50 years. 2. Both male and female. 3. Unilateral bell's paralysis. 4. Not congenital in origin. 5. Sub-acute and chronic cases.

Exclusion criteria

1. Other neurological deficits include epilepsy and Alzheimer's disease. 2. Traumatic onset. 3. Surgical reconstruction (nerve or muscle reconstruction). 4. Mental and psychological disorders i.e., schizophrenia, bipolar disorders. 5. Skin diseases (eczema, urticarial) as electrical stimulation may affect the results. 6. Any contraindications for massage like sunburn, bruising, or cuts.

Design outcomes

Primary

MeasureTime frameDescription
Change in SynkinesisIt will be assessed at baseline, at the third week and at six week.Synkinesis will be accessed through the House-Brackmann Scale. It is classified as a universal scale. This scale analyses the symmetry, synkinesis, stiffness, and global mobility of the face. It is divided into six categories (normal, mild dysfunction, moderate dysfunction, moderately severe dysfunction, severe dysfunction, and total paralysis) and is a 0-6-point scale with 6 representing total paralysis.
Level of Facial DisabilityChange in functional status will be measured at the baseline, at 3rd week and at 6th week.The level of Facial disability will be measured through the Facial Disability Index Scale. This scale has ten items that evaluate the patient's physical and social aspects (mastication, deglutition, communication, labial mobility, emotional alterations, and social integration). It uses a hundred-point scale with a higher score indicating less impairment. 24 Minimum score for physical functioning: 0, Maximum score for physical functioning: 25, Minimum score for social and well-being: 5, Maximum score for social and well-being.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026